{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:52:09Z","timestamp":1791067929134,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106262","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:38:24Z","timestamp":1789745904000},"page":"106262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline cancer predisposition gene mutations and upgrade rate to breast cancer among patients with pleomorphic and florid lobular carcinoma in situ"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9288-8056","authenticated-orcid":false,"given":"Komal","family":"Ijaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese Bartholomew","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9156-8723","authenticated-orcid":false,"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-3947","authenticated-orcid":false,"given":"Lavinia P.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.humpath.2026.106262_bib1","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1016\/j.humpath.2026.106262_bib2","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106262_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.humpath.2026.106262_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/tbj\/3580992","article-title":"Florid lobular carcinoma in situ: imaging characteristics and pathologic upgrade rates on surgical excision","volume":"2025","author":"Desai","year":"2025","journal-title":"Breast J"},{"issue":"12","key":"10.1016\/j.humpath.2026.106262_bib5","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106262_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106262_bib7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41379-021-00796-9","article-title":"Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision","volume":"34","author":"Kuba","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106262_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100462","article-title":"Upgrade rates of variant lobular carcinoma in situ compared to classic lobular carcinoma in situ diagnosed in core needle biopsies: a 10-Year single institution retrospective study","volume":"37","author":"Harinath","year":"2024","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106262_bib9","article-title":"Clinical management and oncologic outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: results from a large single institution experience","volume":"51","author":"Ferrucci","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106262_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-025-07771-x","article-title":"Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ","volume":"213","author":"Middleton","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2026.106262_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2026.104711","article-title":"Pleomorphic and florid lobular carcinoma in situ of the breast: a systematic review of current evidence and knowledge gaps","volume":"86","author":"Ferrucci","year":"2026","journal-title":"Breast"},{"key":"10.1016\/j.humpath.2026.106262_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106262_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1806","article-title":"Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity","volume":"207","author":"Reis-Filho","year":"2005","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106262_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41379-020-0459-6","article-title":"Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERBB3 alterations","volume":"33","author":"Harrison","year":"2020","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106262_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/jnci\/djaa023","article-title":"The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort","volume":"112","author":"Hu","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"35","key":"10.1016\/j.humpath.2026.106262_bib16","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast","volume":"39","author":"Yadav","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106262_bib17","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1245\/s10434-024-14947-0","article-title":"Upgrade rates and breast cancer development among germline pathogenic variant carriers with high-risk breast lesions","volume":"31","author":"Laws","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106262_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/genes12050616","article-title":"Clinicopathologic profile of breast cancer in germline ATM and CHEK2 mutation carriers","volume":"12","author":"Toss","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.humpath.2026.106262_bib19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1055-9965.EPI-18-1102","article-title":"Frequency of pathogenic germline variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in sporadic lobular breast cancer","volume":"28","author":"Petridis","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2026.106262_bib20","series-title":"Breast tumours. Lyon (France)","year":"2019"},{"issue":"1","key":"10.1016\/j.humpath.2026.106262_bib21","first-page":"77","article-title":"Genetic\/familial high risk assessment: breast, ovarian and pancreatic version","volume":"19","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2026.106262_bib22","unstructured":"NCCN Practice Guidelines in Oncology, Breast Cancer Screen Diagnos, p25 https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdfVersion2.2025 accessed.12.20.2025."},{"key":"10.1016\/j.humpath.2026.106262_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.humpath.2026.106262_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","article-title":"Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ","volume":"38","author":"Masannat","year":"2018","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.humpath.2026.106262_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","article-title":"Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria","volume":"56","author":"Xicola","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2026.106262_bib27","article-title":"Germline pathogenic variants and breast cancer phenotypes in a European multicenter cohort","volume":"10","author":"Rodriguez-Hernandez","year":"2025","journal-title":"ESMO Open"},{"issue":"12","key":"10.1016\/j.humpath.2026.106262_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104359","article-title":"Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: an integrated evaluation of germline and somatic genomic results","volume":"64","author":"Rana","year":"2021","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106262_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1897-4287-12-16","article-title":"Large deletion causing von Hippel-Lindau disease and hereditary breast cancer syndrome","volume":"12","author":"Krzystolik","year":"2014","journal-title":"Hered Cancer Clin Pract"},{"issue":"3","key":"10.1016\/j.humpath.2026.106262_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-024-07261-6","article-title":"Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants","volume":"2024","author":"Chung","year":"2024","journal-title":"Breast Cancer Res Treat"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:55:34Z","timestamp":1791064534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0046817726002315"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106262","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline cancer predisposition gene mutations and upgrade rate to breast cancer among patients with pleomorphic and florid lobular carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106262"}}